Informations générales (source: ClinicalTrials.gov)

NCT05450796 En recrutement IDF
Prognosis and Virulence Determination of Capsule and Endotoxin During Klebsiella Spp. Ventilator-associated Pneumonias (PROVIDENCE)
Observational
  • Pneumopathie infectieuse
  • Pneumopathie infectieuse sous ventilation assistée
Fondation Hôpital Saint-Joseph (Voir sur ClinicalTrials)
juin 2022
décembre 2024
29 juin 2024
Ventilator-associated pneumonia is the leading cause of nosocomial infection in the ICU. The pathogens responsible are multiple, but enterobacteria constitute a major source of pathogens involved. Within this family, Klebsiella spp. and Escherichia coli are the two most frequent genera, with Klebsiella spp. often present in severe forms. The factors associated with the occurrence of Ventilator-associated pneumonia and its adverse course depend on host defenses and the virulence of the pathogen. The virulence of Klebsiella spp. depends on several structures, notably the presence of a capsule, the particularities of its lipopolysaccharide, its adhesins (type 3 fimbriae), its capacity to capture iron (siderophores). The objective of this work is to evaluate the role of these different virulence mechanisms in the evolution of Ventilator-associated pneumonia and the hospital prognosis.
 Voir le détail

Etablissements

Les établissements d'Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données
GH PARIS SITE SAINT JOSEPH Helene BEAUSSIER, PharmD, PhD En recrutement IDF Contact (sur clinicalTrials)

Critères

Tous
Inclusion Criteria:

- Patient whose age is ≥ 18 years

- Patient hospitalized in an intensive care unit

- Patient with ventilator-associated Klebsiella spp. pneumonia

- French-speaking patient


- Patient with a severe psychiatric disorder

- Patient under guardianship or curatorship

- Patient deprived of liberty

- Patient under court protection

- Patient who objects to the use of his or her data for this research